NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Multicenter Trial To Evaluate Oral Retrovir in the Treatment of Children With Symptomatic HIV Infection

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-14

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 70

Registration Number: NCT00000716

Locations: 🇺🇸
Univ of Miami School of Medicine, Miami, Florida, United States
🇺🇸
Johns Hopkins Hosp - Pediatric, Baltimore, Maryland, United States
🇺🇸
Johns Hopkins Hosp, Baltimore, Maryland, United States

and more 6 locations

A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC)

Phase 2

Terminated

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-14

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 80

Registration Number: NCT00000659

Locations: 🇺🇸
Tulane Univ School of Medicine, New Orleans, Louisiana, United States
🇺🇸
Bellevue Hosp / New York Univ Med Ctr, New York, New York, United States

Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis

Not Applicable

Completed

Conditions: Meningitis, Cryptococcal
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-14

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 120

Registration Number: NCT00000708

Locations: 🇺🇸
Univ of Miami School of Medicine, Miami, Florida, United States
🇺🇸
Julio Arroyo, West Columbia, South Carolina, United States
🇺🇸
Tulane Univ School of Medicine, New Orleans, Louisiana, United States

and more 3 locations

A Study of Azidothymidine Plus Methadone in Patients With AIDS and AIDS Related Complex (ARC)

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-14

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 18

Registration Number: NCT00001008

Locations: 🇺🇸
Montefiore Med Ctr / Bronx Municipal Hosp, Bronx, New York, United States

(Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) Versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-14

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 600

Registration Number: NCT00000679

Locations: 🇺🇸
Graduate Hosp, Philadelphia, Pennsylvania, United States
🇺🇸
New England Med Ctr, Boston, Massachusetts, United States
🇺🇸
Ctr for Special Immunology, Fort Lauderdale, Florida, United States

and more 22 locations

A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS

Phase 3

Completed

Conditions: Cytomegalovirus Retinitis
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-14

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 180

Registration Number: NCT00000688

Locations: 🇺🇸
Univ of California / San Diego Treatment Ctr, San Diego, California, United States
🇺🇸
Stanford Univ School of Medicine, Stanford, California, United States
🇺🇸
Kansas City Veterans Administration Med Ctr, Kansas City, Missouri, United States

and more 19 locations

Comparison of ddI Versus Zidovudine in HIV-Infected Patients

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-14

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 1500

Registration Number: NCT00000979

Locations: 🇺🇸
Whitman - Walker Clinic, Washington, District of Columbia, United States
🇺🇸
Beth Israel Deaconess Med Ctr, Boston, Massachusetts, United States
🇺🇸
Med Ctr of Central Massachusetts, Worcester, Massachusetts, United States

and more 68 locations

A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 74

Registration Number: NCT00001122

Locations: 🇺🇸
UCSD, San Diego, California, United States
🇺🇸
Univ of Texas Southwestern Med Ctr, Dallas, Texas, United States

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 288

Registration Number: NCT00001119

Locations: 🇺🇸
Seattle HIVNET, Seattle, Washington, United States
🇺🇸
Univ of Washington, Seattle, Washington, United States
🇺🇸
Univ of Minnesota, Minneapolis, Minnesota, United States

and more 9 locations

A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 42

Registration Number: NCT00000897

Locations: 🇺🇸
Children's Hosp at Albany Med Ctr, Albany, New York, United States
🇺🇸
SUNY / Erie County Med Ctr at Buffalo, Buffalo, New York, United States
🇺🇸
Univ of Washington, Seattle, Washington, United States

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy